Uncovering androgen responsive regulatory networks in prostate cancer

OCCBIO'09: 2009 Ohio Collaborative Conference on Bioinformatics

Volumn , Issue , 2009, Pages 99-103

  Eisermann, Kurtis ^a   Bazarov, Anton ^a   Brett, Adina ^a   Knapp, Ethan ^a   Piontkivska, Helen ^a   Fraizer, Gail ^a  

^a KENT STATE UNIVERSITY   (United States)

Author keywords

AR; EGR1; Evolutionary conservation; SP1; Transcription factor binding site; WT1

Indexed keywords

AR; EGR1; EVOLUTIONARY CONSERVATION; SP1; TRANSCRIPTION FACTOR BINDING SITE; WT1;

BINDING ENERGY; BIOINFORMATICS; CELLS; GENES; MAMMALS; TARGETS; TRANSCRIPTION; TRANSCRIPTION FACTORS; ZINC;

BINDING SITES;

EID: 70350431754     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1109/OCCBIO.2009.21     Document Type: Conference Paper

References (26)

1. Bolton EC, So AY, Chaivorapol C, Haqq CM, Li H, Yamamoto KR: Cell- and gene-specific regulation of primary target genes by the androgen receptor. Genes Dev 2007, 21:2005-2017.
2. Wang Q, Li W, Liu XS, Carroll JS, Janne OA, Keeton EK, Chinnaiyan AM, Pienta KJ, Brown M: A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth. Mol Cell 2007, 27:380-392.
3. Massie CE, Adryan B, Barbosa-Morais NL, Lynch AG, Tran MG, Neal DE, Mills IG: New androgen receptor genomic targets show an interaction with the ETS1 transcription factor. EMBO Rep 2007, 8:871.
4. Brown K: Differential Gene Expression Patterns in Prostate Cancer Epithelial and Interstitial Stromal Cells. MS Thesis, Kent State University; 2006.
5. Eisermann K, Tandon S, Bazarov A, Brett A, Fraizer G, Piontkivska H: Evolutionary conservation of zinc finger transcription factor binding sites in promoters of genes co-expressed with WT1 in prostate cancer. BMC Genomics 2008, 9:337.
6. Lonard DM, O'Malley BW: The Expanding Cosmos of Nuclear Receptor Coactivators. Cell 2006, 125:411-414.
7. Rauscher FJ, Morris JF, Tournay OE, Cook DM, Curran T: Binding of the Wilms' tumor locus zinc finger protein to the EGR-1 consensus sequence. Science 1990, 250:1259-1262.
8. Liu C, Calogero A, Ragona G, Adamson E, Mercola D: EGR-1, the reluctant suppression factor: EGR-1 is known to function in the regulation of growth, differentiation, and also has significant tumor suppressor activity and a mechanism involving the induction of TGF-beta1 is postulated to account for this suppressor activity. Crit Rev Oncog 1996, 7:101-125.
9. Lu S, Jenster G, Epner DE: Androgen Induction of Cyclin-Dependent Kinase Inhibitor p21 Gene: Role of Androgen Receptor and Transcription Factor Sp1 Complex. Molecular Endocrinology 2000, 14:753-760.
10. Owen GI, Richer JK, Tung L, Takimoto G, Horwitz KB: Progesterone Regulates Transcription of the p21 WAF1 Cyclindependent Kinase Inhibitor Gene through Sp1 and CBP/p300. J Biol Chem 1998, 273:10696-10701.
11. Chen PH, Tsao YP, Wang CC, Chen SL: Nuclear receptor interaction protein, a coactivator of androgen receptors (AR), is regulated by AR and Sp1 to feed forward and activate its own gene expression through AR protein stability. Nucleic Acids Res 2008, 36:51-66.
12. Muller MD, Vigne JL, Michenko A, Lebovic DI, Leitman DC, Taylor RN: Regulation of Vascular Endothelial Growth Factor (VEGF) Gene Transcription by Estrogen Receptors a and b. PNAS 2000, 97:10972-10977.
13. Stoner M, Wormke M, Saville B, Samudio I, Qin C, Abdelrahim M, Safe S: Estrogen regulation of vascular endothelial growth factor gene expression in ZR-75 breast cancer cells through interaction of estrogen receptor alpha and SP proteins. Oncogene 2004, 23:1052-1063.
14. Reizner N, Maor S, Sarfstein R, Abramovitch S, Welshons WV, Curran EM, Lee AV, Werner H: The WT1 Wilms' tumor suppressor gene product interacts with estrogen receptor-alpha and regulates IGF-I receptor gene transcription in breast cancer cells. J Mol Endocrinol 2005, 35:135-144.
15. Culig Z, Comuzzi B, Steiner H, Bartsch G, Hobish A: Expression and function of androgen receptor coactivators in prostate cancer. J Steroid Biochem Mol Biol 2004, 92:265-271.
16. Wang W, Lee SB, Palmer R, Ellisen LW, Haber DA: A functional interaction with CBP contributes to transcriptional activation by the Wilms tumor suppressor WT1. J Biol Chem 2001, 276:16810-16816.
17. Ensembl Genome Browser [http://www.ensembl.org/].
18. Rutherford K, Parkhill J, Crook J, Horsnell T, Rice P, Rajandream MA, Barrell B: Artemis: sequence visualization and annotation. Bioinformatics 2000, 16:944-945.
19. Cartharius K, Frech K, Grote K, Klocke B, Haltmeier M, Klingenhoff A, Frisch M, Bayerlein M, Werner T: MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 2005, 21:2933-2942.
20. Wingender E, Chen X, Hehl R, Karas H, Liebich I, Matys V, Meinhardt T, Prüß M, Reuter I, Schacherer F: TRANSFAC: an integrated system for gene expression regulation. Nucleic Acids Res 2000, 28:316-319.
21. Berquin IM, Min Y, Wu R, Wu H, Chen YQ: Expression signature of the mouse prostate. J Biol Chem 2005, 280:36442-36451.
22. Dutton JR, Lahiri D, Ward A: Different isoforms of the Wilms' tumour protein WT1 have distinct patterns of distribution and trafficking within the nucleus. Cell Prolif 2006, 39:519-535.
23. Hanson J, Gorman J, Reese J, Fraizer G: Regulation of vascular endothelial growth factor, VEGF, gene promoter by the tumor suppressor, WT1. Front Biosci 2007, 12:2279-2290.
24. Weinmann AS, Farnham PJ: Identification of unknown target genes of human transcription factors using chromatin immunoprecipitation. Methods 2002, 26:37-47.
25. Madden SL, Cook DM, Morris JF, Gashler A, Sukhatme VP, Rauscher III FJ: Transcriptional repression mediated by the WT1 Wilms tumor gene product. Science 1991, 253:1550.
26. Kim H, Kim MS, Hancock AL, Harper JCP, Park JY, Poy G, Perantoni AO, Cam M, Malik K, Lee SB: Identification of Novel Wilms' Tumor Suppressor Gene Target Genes Implicated in Kidney Development. J Biol Chem 2007, 282:16278-16287.